Skip to content

Study · Not a test of the peptide alone · 2013

1 result

Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.

Ferrero S, Leone Roberti Maggiore U, Scala C, Di Luca M, Venturini PL, Remorgida V

Archives of gynecology and obstetrics9 Oct 2012Cited by 41 (Europe PMC)

PMID23053314 (opens in a new tab)DOI10.1007/s00404-012-2581-2 (opens in a new tab)PepBankPUB-23053314
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneNon-randomized trialEfficacy outcome

    In women with rectovaginal endometriosis, nodule volume decreased after 12 months in every regimen group, including triptorelin plus tibolone.

    In plain wordsIn women with rectovaginal endometriosis, nodule volume decreased after 12 months in every regimen group, including triptorelin plus tibolone.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseNodule volume in triptorelin plus tibolone group
    Study

    n: not reported in source

    Comparator
    Baseline
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    After 12-month treatment, the volume of the nodules decreased in all study groups.
    2 context sentences
    Summary · context
    This prospective, non-randomized, self-controlled clinical trial included patients with rectovaginal endometriotic nodules infiltrating at least the muscularis propria of the rectum,
    Summary · context
    who received one of the following therapies: norethisterone acetate, triptorelin and tibolone, norethisterone acetate and letrozole, desogestrel, sequential oral contraceptive pill.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.